113 related articles for article (PubMed ID: 32991890)
1. Botryosphaeran, a (1 → 3)(1 → 6)-β-D-glucan, reduces tumor development and cachexia syndrome in obese male rats by increasing insulin sensitivity and FOXO3a activity.
Geraldelli D; Ribeiro MC; Medeiros TC; Comiran PK; Martins KO; Oliveira MF; Oliveira GA; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
Int J Biol Macromol; 2020 Dec; 165(Pt A):985-994. PubMed ID: 32991890
[TBL] [Abstract][Full Text] [Related]
2. Tumor development in rats and cancer cachexia are reduced by treatment with botryosphaeran by increasing apoptosis and improving the metabolic profile.
Geraldelli D; Ribeiro MC; Medeiros TC; Comiran PK; Martins KO; Oliveira MF; Oliveira GA; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
Life Sci; 2020 Jul; 252():117608. PubMed ID: 32289434
[TBL] [Abstract][Full Text] [Related]
3. Botryosphaeran reduces obesity, hepatic steatosis, dyslipidaemia, insulin resistance and glucose intolerance in diet-induced obese rats.
Silva AZ; Costa FPL; Souza IL; Ribeiro MC; Giordani MA; Queiroz DA; Luvizotto RAM; Nascimento AF; Bomfim GF; Sugizaki MM; Dekker RFH; Barbosa-Dekker AM; Queiroz EAIF
Life Sci; 2018 Oct; 211():147-156. PubMed ID: 30227131
[TBL] [Abstract][Full Text] [Related]
4. Botryosphaeran Attenuates Tumor Development and the Cancer Cachexia Syndrome in Walker-256 Tumor-Bearing Obese Rats and Improves the Metabolic and Hematological Profiles of These Rats.
Comiran PK; Ribeiro MC; Silva JHG; Martins KO; Santos IA; Chiaradia AEF; Silva AZ; Dekker RFH; Barbosa-Dekker AM; Alegranci P; Queiroz EAIF
Nutr Cancer; 2021; 73(7):1175-1192. PubMed ID: 32643421
[TBL] [Abstract][Full Text] [Related]
5. Extended treatment with (1→3)(1→6)-β-d-glucan (Botryosphaeran) reduces obesity and its comorbidities in high-fat/high-sugar diet-fed rats.
Ribeiro MC; Silva AZD; Giordani MA; Lira C; Luvizotto RAM; Nascimento AF; Queiroz DA; Dekker RFH; Barbosa-Dekker AM; de Queiroz EAIF
Cell Biochem Funct; 2022 Oct; 40(7):773-783. PubMed ID: 36111697
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant, anti-inflammatory and beneficial metabolic effects of botryosphaeran [(1→3)(1→6)-β-d-glucan] are responsible for its anti-tumour activity in experimental non-obese and obese rats bearing Walker-256 tumours.
da Silva TP; Geraldelli D; Martins KO; Braga AJL; Rosa AP; Ferneda JMA; Bomfim GF; Barbosa-Dekker AM; Dekker RFH; Dias MC; Paim NP; Sinhorin VDG; de Queiroz EAIF
Cell Biochem Funct; 2022 Feb; ():. PubMed ID: 35229356
[TBL] [Abstract][Full Text] [Related]
7. Anticlastogenic activity exhibited by botryosphaeran, a new exopolysaccharide produced by Botryosphaeria rhodina MAMB-05.
Miranda CC; Dekker RF; Serpeloni JM; Fonseca EA; Cólus IM; Barbosa AM
Int J Biol Macromol; 2008 Mar; 42(2):172-7. PubMed ID: 18022685
[TBL] [Abstract][Full Text] [Related]
8. Hypoglycemic and Hypocholesterolemic Effects of Botryosphaeran from Botryosphaeria rhodina MAMB-05 in Diabetes-Induced and Hyperlipidemia Conditions in Rats.
Miranda-Nantes CC; Fonseca EA; Zaia CT; Dekker RF; Khaper N; Castro IA; Barbosa AM
Mycobiology; 2011 Sep; 39(3):187-93. PubMed ID: 22783102
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative and pro-apoptotic effects of three fungal exocellular β-glucans in MCF-7 breast cancer cells is mediated by oxidative stress, AMP-activated protein kinase (AMPK) and the Forkhead transcription factor, FOXO3a.
Queiroz EA; Fortes ZB; da Cunha MA; Barbosa AM; Khaper N; Dekker RF
Int J Biochem Cell Biol; 2015 Oct; 67():14-24. PubMed ID: 26255117
[TBL] [Abstract][Full Text] [Related]
10. Sulfonation and anticoagulant activity of botryosphaeran from Botryosphaeria rhodina MAMB-05 grown on fructose.
Mendes SF; dos Santos O; Barbosa AM; Vasconcelos AF; Aranda-Selverio G; Monteiro NK; Dekker RF; Sá Pereira M; Tovar AM; Mourão PA; da Silva Mde L
Int J Biol Macromol; 2009 Oct; 45(3):305-9. PubMed ID: 19549543
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of botryosphaeran [(1 → 3)(1 → 6)-β-d-glucan] reduces inflammation through modulation of leukocytes and has limited effect on inflammatory nociception.
Silva NA; Pereira BG; Santos JA; Guarnier FA; Barbosa-Dekker AM; Dekker RFH; Kassuya CAL; Bernardes SS
Cell Biochem Funct; 2022 Aug; 40(6):578-588. PubMed ID: 35788958
[TBL] [Abstract][Full Text] [Related]
12. In vivo antimutagenic and antiatherogenic effects of the (1 → 3)(1 → 6)-β-d- glucan botryosphaeran.
Silva-Sena GG; Malini M; Delarmelina JM; Dutra JCV; Gervásio SV; Leal MAS; Costa Pereira TM; Barbosa-Dekker AM; Dekker RFH; de Paula F; Batitucci MDCP
Mutat Res Genet Toxicol Environ Mutagen; 2018 Feb; 826():6-14. PubMed ID: 29412871
[TBL] [Abstract][Full Text] [Related]
13. Chemical modification of botryosphaeran: structural characterization and anticoagulant activity of a water-soluble sulfonated (1-->3)(1-->6)-β-D-glucan.
Brandi J; Oliveira ÉC; Monteiro N; Vasconcelos AF; Dekker RF; Barbosa AM; Silveira JL; Mourão PA; Corradi da Silva Mde L
J Microbiol Biotechnol; 2011 Oct; 21(10):1036-42. PubMed ID: 22031027
[TBL] [Abstract][Full Text] [Related]
14. Modulation of gene expression and cell cycle by botryosphaeran, a (1→3)(1→6)-β-d-glucan in human lymphocytes.
Malini M; Souza MF; Oliveira MT; Antunes LM; Figueiredo SG; Barbosa AM; Dekker RF; Cólus IM
Int J Biol Macromol; 2015; 77():214-21. PubMed ID: 25795388
[TBL] [Abstract][Full Text] [Related]
15. Free-radical scavenging properties and antioxidant activities of botryosphaeran and some other β-D-glucans.
Giese EC; Gascon J; Anzelmo G; Barbosa AM; da Cunha MA; Dekker RF
Int J Biol Macromol; 2015 Jan; 72():125-30. PubMed ID: 25128096
[TBL] [Abstract][Full Text] [Related]
16. Structural characterization of Botryosphaeran: a (1-->3;1-->6)-beta-D-glucan produced by the ascomyceteous fungus, Botryosphaeria sp.
Barbosa AM; Steluti RM; Dekker RF; Cardoso MS; Corradi da Silva ML
Carbohydr Res; 2003 Jul; 338(16):1691-8. PubMed ID: 12873424
[TBL] [Abstract][Full Text] [Related]
17. Toxicological and immunomodulatory assessments of botryosphaeran (β-glucan) produced by Botryosphaeria rhodina RCYU 30101.
Weng BB; Lin YC; Hu CW; Kao MY; Wang SH; Lo DY; Lai TY; Kan LS; Chiou RY
Food Chem Toxicol; 2011 Apr; 49(4):910-6. PubMed ID: 21185904
[TBL] [Abstract][Full Text] [Related]
18. Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a.
de Queiroz EA; Akamine EH; de Carvalho MH; Sampaio SC; Fortes ZB
Life Sci; 2015 Jan; 121():78-87. PubMed ID: 25497710
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effect and lack of genotoxicity and mutagenicity of the exopolysaccharide botryosphaeran on human lymphocytes.
Malini M; Camargo MS; Hernandes LC; Vargas-Rechia CG; Varanda EA; Barbosa AM; Dekker RFH; Matsumoto ST; Antunes LMG; Cólus IMS
Toxicol In Vitro; 2016 Oct; 36():18-25. PubMed ID: 27387458
[TBL] [Abstract][Full Text] [Related]
20. In vitro protective effects of botryosphaeran, a (1→3;1→6)-β-d-glucan, against mutagens in normal and tumor rodent cells.
Kerche-Silva LE; Cólus IM; Malini M; Mori MP; Dekker RF; Barbosa-Dekker AM
Mutat Res Genet Toxicol Environ Mutagen; 2017 Feb; 814():29-36. PubMed ID: 28137365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
